澳大利亚在国家指南发布后对慢性阻塞性肺疾病的管理。

Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines.

机构信息

Southern Health Pharmacy Department, Casey Hospital and Department of Pharmacy Practice, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.

出版信息

Intern Med J. 2011 Mar;41(3):263-70. doi: 10.1111/j.1445-5994.2009.02133.x.

DOI:10.1111/j.1445-5994.2009.02133.x

PMID:20002857

Abstract

BACKGROUND

Information on the management of chronic obstructive pulmonary disease (COPD) in Australia, especially the extent of adherence to the COPD-X Plan, is sparse.

AIM

To evaluate COPD patient adherence to treatment recommendations and healthcare provider adherence to the COPD-X Plan.

METHODS

Cross-sectional study of patients admitted to a secondary care hospital with an acute exacerbation of COPD over a 6-month period. Data were collected from patient interviews and medical notes.

RESULTS

Participants (n= 45) aged 72 ± 11.5 years (mean ± SD) had a mean FEV(1) % predicted 52.2 ± 18.7. At the time 11 (24.4%) patients continued to smoke; 25 (55.6%) had never participated in a pulmonary rehabilitation programme; and 23 (51.1%) self-reported poor adherence to some COPD medications. Inhaler technique was deemed suboptimal in 25 (55.6%) patients. Only 11 (24.4%) patients had received any instructions from their doctor regarding management of exacerbations. The use of medications not supported by the COPD-X guidelines were: long-term prednisolone (11, 24.4%) and prophylactic antibiotics (3, 6.7%).

CONCLUSION

Management of COPD in Australia by both patients and providers remains suboptimal despite the publication and wide dissemination of the COPD-X Plan, suggesting the need to intensify both patient and provider education in COPD management.

摘要

背景

有关澳大利亚慢性阻塞性肺疾病（COPD）管理的信息，尤其是对 COPD-X 计划的遵守程度，较为匮乏。

目的

评估 COPD 患者对治疗建议的依从性以及医疗保健提供者对 COPD-X 计划的依从性。

方法

在 6 个月的时间内，对因 COPD 急性加重而住院的二级保健医院患者进行横断面研究。从患者访谈和病历中收集数据。

结果

参与者（n=45）年龄为 72±11.5 岁（平均值±标准差），FEV1%预计值为 52.2±18.7。当时有 11 名（24.4%）患者继续吸烟；25 名（55.6%）从未参加过肺康复计划；23 名（51.1%）自述对某些 COPD 药物的依从性较差。25 名（55.6%）患者的吸入器技术被认为不理想。只有 11 名（24.4%）患者从医生那里获得过关于急性加重管理的任何指导。使用不符合 COPD-X 指南的药物有：长期泼尼松龙（11 例，24.4%）和预防性抗生素（3 例，6.7%）。